Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 2
2002 3
2003 3
2004 6
2005 9
2006 11
2007 10
2008 17
2009 16
2010 18
2011 15
2012 21
2013 14
2014 22
2015 20
2016 27
2017 18
2018 28
2019 23
2020 26
2021 17
2022 19
2023 18
2024 13
2025 13
2026 8

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

344 results

Results by year

Filters applied: . Clear all
Page 1
ESMO-ESTRO consensus statements on the safety of combining radiotherapy with EGFR, ALK, or BRAF/MEK inhibitors.
van Aken ESM, O'Cathail SM, Gandhi AK, Bussink J, Castelo-Branco L, Eriksen JG, Argilés G, Hiley CT, Atkinson V, Kaźmierska J, Calles A, Konopa K, Le Rhun E, McDonald F, Mountzios G, Putora PM, Muoio B, Ricardi U, Westphalen CB, Wrona A, Boot P, Pentheroudakis G, Belka C, Lordick F, Marijnen CAM, Martins-Branco D, De Ruysscher D, Barriuso J, Devnani B, de Jong MC, Prelaj A. van Aken ESM, et al. Among authors: pentheroudakis g. ESMO Open. 2026 Mar;11(3):106076. doi: 10.1016/j.esmoop.2026.106076. Epub 2026 Feb 26. ESMO Open. 2026. PMID: 41759225 Free PMC article.
ESMO adaptation of Lines of Systemic Therapy (EnLiST): a consensus framework for standardising the designation of lines of therapy in solid tumours.
Saini KS, Koopman M, Martins-Branco D, Bossi P, Braendegaard Winther S, Brahmi M, Braña I, Calvo E, Castelo-Branco L, Colombo I, de Azambuja E, De Ruysscher D, Dienstmann R, Dingemans AC, Ekholm M, Gallois C, Golfinopoulos V, Grande E, Halabi S, Le Rhun E, Le Saux O, Leighl NB, Lonardi S, Lorenzen S, Lorusso D, Minniti G, Mountzios G, Oldenburg J, Oosting SF, Osterlund P, Perez-Gracia JL, Pellat A, Piperno-Neumann S, Plummer R, Porta C, Punie K, Ray-Coquard I, Remon J, Ruhlmann CH, Rutkowski P, Siu LL, Stacchiotti S, Suarez C, Suijkerbuijk K, Taieb J, Trapani D, Valachis A, van Laarhoven HWM, Vogel A, Zer A, Pentheroudakis G, Delaloge S, Twelves C. Saini KS, et al. Among authors: pentheroudakis g. Ann Oncol. 2026 May;37(5):608-623. doi: 10.1016/j.annonc.2026.02.008. Epub 2026 Feb 17. Ann Oncol. 2026. PMID: 41713786
Assessing Overall Survival Benefits in Advanced Cancers: The Role of External Comparator Cohort Studies with Real-World Data.
Pignatti F, El-Galaly TC, Kaiser M, Porkka K, Doeswijk R, Mol P, Rivera DR, Lerro CC, Rohr UP, Verpillat P, Valachis A, Trapani D, Di Maio M, Latino N, Cordoba R, Cherny N, Koopman M, Martins-Branco D, Pentheroudakis G, Postmus D. Pignatti F, et al. Among authors: pentheroudakis g. Clin Pharmacol Ther. 2026 Apr;119(4):1080-1087. doi: 10.1002/cpt.70213. Epub 2026 Feb 11. Clin Pharmacol Ther. 2026. PMID: 41669939 Free PMC article.
Anti-EGFR re-challenge with chemotherapy in RAS wild-type advanced colorectal cancer (A-REPEAT study): efficacy and correlations with tissue and plasma genotyping.
Sgouros J, Eliades A, Papadopoulou K, Korfiatis N, Papamichael D, Fountzilas E, Tsolaki E, Achilleos A, Tsangaras K, Loizides C, Oikonomopoulos G, Makatsoris T, Kypri E, Ioannides M, Koumbaris G, Fountzilas G, Patsalis PC, Pentheroudakis G. Sgouros J, et al. Among authors: pentheroudakis g. ESMO Gastrointest Oncol. 2025 Jan 8;7:100120. doi: 10.1016/j.esmogo.2024.100120. eCollection 2025 Mar. ESMO Gastrointest Oncol. 2025. PMID: 41646483 Free PMC article.
Feasibility and impact of Lynch syndrome genetic testing in newly diagnosed colorectal cancer patients: a multicenter observational study in Greece.
Manolakou S, Tsoukalas N, Saloustros E, Makatsoris T, Boukovinas I, Christopoulou A, Karampeazis A, Bompolaki I, Varthalitis II, Voulgaris E, Ballasis K, Boutis A, Galani E, Kalofonos C, Koumarianou A, Kourousis C, Papakotoulas P, Papandreou C, Perdikouri EI, Andreadou A, Athanasiadis I, Dimitrakopoulos FI, Emmanouilidis C, Kampletsas E, Katopodi O, Kosmidis P, Koutsoukos K, Lianos E, Makrantonakis P, Ntouvelis E, Panopoulos C, Papadopoulos V, Pentheroudakis G, Samantas E, Stoupis I, Tsironis G, Chatzifoti N, Souglakos I, Saridaki Z; Hellenic Society of Medical Oncology (HeSMO). Manolakou S, et al. Among authors: pentheroudakis g. ESMO Gastrointest Oncol. 2025 Mar 25;8:100153. doi: 10.1016/j.esmogo.2025.100153. eCollection 2025 Jun. ESMO Gastrointest Oncol. 2025. PMID: 41646271 Free PMC article.
ESMO-ESTRO consensus statements on the safety of combining radiotherapy with CDK4/6, HER2, PARP, or mTOR inhibitors.
van Aken ESM, Gandhi AK, O'Cathail SM, Borst G, Barriuso J, Fokas E, Castelo-Branco L, Ree AH, de Azambuja E, Kroeze S, Colombo I, Levy A, Criscitiello C, Niyazi M, Harbeck N, Szutowicz E, Liposits G, Verheij M, Ray-Coquard I, Tarantino P, Trapani D, Boot P, Belka C, Ruysscher D, Pentheroudakis G, Marijnen CAM, Lordick F, Ricardi U, Martins-Branco D, Prelaj A, de Jong MC, Devnani B. van Aken ESM, et al. Among authors: pentheroudakis g. Radiother Oncol. 2026 Feb;215:111330. doi: 10.1016/j.radonc.2025.111330. Epub 2025 Dec 11. Radiother Oncol. 2026. PMID: 41389857 Free article.
ESMO basic requirements for AI-based biomarkers in oncology (EBAI).
Aldea M, Salto-Tellez M, Marra A, Umeton R, Stenzinger A, Koopman M, Prelaj A, Kehl KL, Gilbert S, Leßmann ME, Lipkova J, Provenzano L, Meric-Bernstam F, Halabi S, Wu J, Pellat A, Suijkerbuijk KPM, Besse B, Ryll B, Marchió C, Crispin-Ortuzar M, Fehrmann R, Vibert J, Ferber D, Pauli C, Valachis A, Corso F, Brinker TJ, Mateo J, Harbeck N, Winkler EC, Lopez-Rios F, Perez-Lopez R, Pentheroudakis G, Delaloge S, Benedikt Westphalen C, Kather JN. Aldea M, et al. Among authors: pentheroudakis g. Ann Oncol. 2026 Mar;37(3):414-430. doi: 10.1016/j.annonc.2025.11.009. Epub 2025 Nov 18. Ann Oncol. 2026. PMID: 41260261 Free article.
ESMO guidance on the use of Large Language Models in Clinical Practice (ELCAP).
Wong EYT, Verlingue L, Aldea M, Franzoi MA, Umeton R, Halabi S, Harbeck N, Indini A, Prelaj A, Romano E, Smyth E, Tan IB, Valachis A, Vibert J, Wiest IC, Yang YH, Gilbert S, Kapetanakis G, Pentheroudakis G, Koopman M, Kather JN. Wong EYT, et al. Among authors: pentheroudakis g. Ann Oncol. 2025 Dec;36(12):1447-1457. doi: 10.1016/j.annonc.2025.09.001. Epub 2025 Oct 18. Ann Oncol. 2025. PMID: 41111032 Free article.
344 results